Tag: Biogens
Biogen’s controversial Alzheimer’s drug generates $2 million in first few weeks after approval
Aduhelm by BiogenSupply: BiogenBiogen's Alzheimer's drug, Adhulem, generated $2 million in income within the first few weeks of its approval, the c [...]
Biogen’s Alzheimer’s drug may value Medicare billions of {dollars} a 12 months: report
A pedestrian walks previous Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021.Adam Glanzman | Bloomberg | Getty PhotosB [...]
Biogen’s new Alzheimer’s drug might price Medicare billions after FDA approval
Medicare, the federal medical health insurance program that covers People over 65, is dealing with an unattainable dilemma: Ought to it cowl a b [...]
Biogen’s Alzheimer’s drug accredited by FDA, first new remedy in almost 20 years
The Meals and Drug Administration on Monday accredited Biogen's Alzheimer's drug aducanumab, making it the primary drug cleared by U.S. regulators [...]
Biotechnology ETFs Soar on Biogen’s New Alzheimer’s Drug
Biotechnology shares and sector-related alternate traded funds stood out Friday after regulators breathed new life into Biogen (NasdaqGS: BIIB) and [...]
Biogen’s Alzheimer’s drug nonetheless faces uphill battle with FDA
A scientist works in a lab at Biogen in Cambridge, MA on Nov. 5, 2016.Suzanne Kreiter | Boston Globe | Getty PhotosBiogen happy shareholders this w [...]
Biogen’s inventory rises 4% after releasing new knowledge on late-stage Alzheimer’s drug
The outside of the headquarters of biotechnology firm Biogen in Cambridge, MA is pictured on March 21, 2019.John Tlumacki | Boston Globe | Getty Pi [...]
Why Biogen’s inventory might fall 10% on new Alzheimer’s drug knowledge
Biogen's inventory might fall as a lot as 10% as soon as it releases new knowledge this week on its Alzheimer's drug, aducanumab, Baird biotech ana [...]
11 / 11 POSTS